243 related articles for article (PubMed ID: 26767854)
1. The antibacterial effect of fatty acids on Helicobacter pylori infection.
Jung SW; Lee SW
Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
Thamphiwatana S; Gao W; Obonyo M; Zhang L
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
Hu Y; Zhang M; Lu B; Dai J
Helicobacter; 2016 Oct; 21(5):349-63. PubMed ID: 26822340
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori.
Obonyo M; Zhang L; Thamphiwatana S; Pornpattananangkul D; Fu V; Zhang L
Mol Pharm; 2012 Sep; 9(9):2677-85. PubMed ID: 22827534
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Helicobacter pylori Infection.
FitzGerald R; Smith SM
Methods Mol Biol; 2021; 2283():1-14. PubMed ID: 33765303
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
[TBL] [Abstract][Full Text] [Related]
7. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
Sarkar A; De R; Mukhopadhyay AK
World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
Dos Santos AA; Carvalho AA
World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.
Smith SM; O'Morain C; McNamara D
World J Gastroenterol; 2014 Aug; 20(29):9912-21. PubMed ID: 25110421
[TBL] [Abstract][Full Text] [Related]
10. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review.
Zaidi SF; Muhammad JS; Usmanghani K; Sugiyama T
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1171-6. PubMed ID: 26051742
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori: microbiology and interactions with gastrointestinal microflora.
Dzierzanowska-Fangrat K; Dzierzanowska D
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():5-14. PubMed ID: 17033102
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori: past, current and future treatment strategies with gastroretentive drug delivery systems.
Verma A; Dubey J; Hegde RR; Rastogi V; Pandit JK
J Drug Target; 2016 Dec; 24(10):897-915. PubMed ID: 27027827
[TBL] [Abstract][Full Text] [Related]
13. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Thombre NA; Gide PS
Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
[TBL] [Abstract][Full Text] [Related]
14. The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Aktaş B; Başyiğit S; Yüksel O; Akkan T; Atbaşı ST; Uzman M; Yılmaz B; Şimşek G; Nazlıgül Y
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):769-75. PubMed ID: 25919773
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
[TBL] [Abstract][Full Text] [Related]
16. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic therapy for Helicobacter pylori.
Collins J; Ali-Ibrahim A; Smoot DT
Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
Menchicchi B; Hensel A; Goycoolea FM
Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
[TBL] [Abstract][Full Text] [Related]
19. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
